Sandhill Capital Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,582
| Closed | -$222K | – | 101 |
|
|
2024
Q4 | $222K | Sell |
2,582
-100
| -4% | -$8.6K | 0.02% | 86 |
|
|
2024
Q3 | $319K | Buy |
2,682
+100
| +4% | +$11.9K | 0.02% | 80 |
|
|
2024
Q2 | $369K | Hold |
2,582
| – | – | 0.03% | 75 |
|
|
2024
Q1 | $332K | Sell |
2,582
-500
| -16% | -$64.2K | 0.03% | 75 |
|
|
2023
Q4 | $319K | Hold |
3,082
| – | – | 0.03% | 72 |
|
|
2023
Q3 | $280K | Hold |
3,082
| – | – | 0.03% | 77 |
|
|
2023
Q2 | $249K | Hold |
3,082
| – | – | 0.02% | 75 |
|
|
2023
Q1 | $245K | Sell |
3,082
-600
| -16% | -$47.7K | 0.02% | 73 |
|
|
2022
Q4 | $249K | Buy |
+3,682
| New | +$249K | 0.03% | 75 |
|
|
2022
Q3 | – | Sell |
-3,682
| Closed | -$205K | – | 88 |
|
|
2022
Q2 | $205K | Hold |
3,682
| – | – | 0.02% | 79 |
|
|
2022
Q1 | $204K | Buy |
+3,682
| New | +$204K | 0.02% | 83 |
|